Sudarshan Pharma's share capital increased to ₹24.96 crore after allotting 90 lakh equity shares from warrant conversions. Promoter shareholding rose to 58.93%, while non-promoters hold 41.07%. The allotment enhances capital base and share value.
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.